1.

Multivariate analysis of prognostic factors for patients with ovarian cancer

Clinical factors	β	SE	Wald	df	Sig.	Exp (B)	95% CI for Exp (B)
							Lower	Upper
CA, carbohydrate antigen; ITIH4, inter-α-trypsin inhibitor heavy chain 4; SE, standard error; 95% CI, 95% confidence interval.
Clinical staging	−1.044	0.461	5.133	1	0.023	0.352	0.143	0.869
Pathologic types	−1.140	0.593	3.699	1	0.054	0.320	0.100	1.022
Tissue grade	1.392	0.533	6.817	1	0.009	4.021	1.415	11.430
Ascites	0.215	0.400	0.289	1	0.591	1.239	0.566	2.713
Pelvic metastasis	−1.192	0.472	6.381	1	0.012	0.304	0.120	0.766
Lymphatic metastasis	−0.447	0.422	1.119	1	0.290	0.640	0.280	1.463
Residual	−0.149	0.554	0.072	1	0.788	0.862	0.291	2.550
CA125	0.336	0.571	0.346	1	0.556	1.099	0.457	4.286
Neoadjuvant chemotherapy	0.093	0.265	0.124	1	0.725	1.097	0.653	1.843
Age	0.013	0.015	0.737	1	0.391	1.013	0.983	1.044
ITIH4 expression quantity	−0.204	0.365	0.313	1	0.576	0.815	0.399	1.667
ITIH4 expression	0.982	0.570	2.972	1	0.085	2.669	0.874	8.151